Nostopharma: Funding, Investors & Team (Oct 2026)
Nostopharma offers treatment for pathological bone growth that aims to prevent a rare bone disease. Their treatment helps patients generate new bone after surgeries, burns, injuries, and other traumas, allowing healthcare providers to effectively treat their patients.
Nostopharma has raised $500k across 2 funding rounds on record, the most recent a Pre-Seed of $250k announced in Jan 2025.
That round is below the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
Nostopharma Company Profile and Key Stats
Latest funding round on record: Jan 2025.
Nostopharma Funding Rounds
Nostopharma raised $250k in an undisclosed round announced in Jun 2023.
1.6 years later, a Pre-Seed of $250k was announced in Jan 2025.
Nostopharma Founders and Leadership Team
Contact details for the Nostopharma team: 1 of 1 has an email address on file.
Start 14-day free trial →Nostopharma Funding Compared to Other Health Care Startups
Nostopharma's latest round of $250k is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Nostopharma in Health Care and Bethesda
Companies Similar to Nostopharma
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
Nostopharma Funding FAQs
What does Nostopharma do?
Nostopharma offers treatment for pathological bone growth that aims to prevent a rare bone disease. Their treatment helps patients generate new bone after surgeries, burns, injuries, and other traumas, allowing healthcare providers to effectively treat their patients.
How much funding has Nostopharma raised?
Nostopharma has raised $500k across 2 rounds on record. The most recent is a Pre-Seed of $250k announced in Jan 2025.
When did Nostopharma last raise funding?
Nostopharma's most recent funding round on record is a Pre-Seed of $250k, announced in Jan 2025.
Who founded Nostopharma?
FundedIQ lists Jelena Jeremic (Founder) at Nostopharma.
Where is Nostopharma headquartered?
Nostopharma is based in Bethesda, Maryland, United States.
How many employees does Nostopharma have?
Nostopharma is in the 1-10 employee band.
How does Nostopharma's funding compare to other Health Care startups?
Nostopharma's latest round of $250k is below the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's Nostopharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Nostopharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.